Loading company…
Youjia Bio develops nucleic acid drugs and drug delivery technologies.
Established in 2019 and based in Hangzhou, China, Youjia Bio researches and develops nucleic acid drugs. Its platform includes drug design, delivery systems, drug evaluation, and polymer-based multi-dose formulations for applications in antiviral, antifibrotic, and cardiovascular treatments. In 2022, it raised an undisclosed amount in Series A+ funding led by Shanxi Growth Enterprise Leading Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in